Clinical scope and treatment goals
Pain research includes different conditions, causes and treatment needs. NICE recommends considering appropriately delivered CBT or acceptance and commitment therapy for chronic primary pain; this specific recommendation should not be generalized to every chronic pain diagnosis (NICE, 2021). Psychological approaches can target distress and the effects of pain on daily life within broader care. The interpretation is that biological, psychological and social dimensions may all deserve attention, rather than that physical assessment becomes unnecessary. ACT and CBT should retain distinct labels even where a guideline presents both as options.
Sources: NICE, 2021
How much difference does CBT make?
The 2020 Cochrane review found very small average pain effects against active controls and somewhat larger, still small effects against usual care. Disability and distress outcomes also varied in magnitude and certainty (Williams et al., 2020). This comparison pattern is central to an honest account: a programme may add more to limited usual care than to another credible intervention. Statistical significance does not establish a large practical benefit for every participant. Follow-up findings also depend on the outcome and comparator; the review is not evidence that all treatment effects last unchanged.
Sources: Williams et al., 2020
An active alternative and functional outcomes
A trial in adults with nonspecific chronic low back pain compared group CBT, mindfulness-based stress reduction and usual care. Both structured programmes produced more functional improvement than usual care at twenty-six weeks, with no significant difference between the active approaches (Cherkin et al., 2016). Its definition of improvement required a meaningful change from each participant’s baseline. This helps distinguish function from complete pain relief. Later findings differed by outcome and analysis, so the study should not be reduced to a claim that every benefit persisted for a year. Group attendance, missing observations and the single healthcare system also limit generalization.
Sources: Cherkin et al., 2016
Remote delivery, safety and durability
The 2023 Cochrane review found small end-of-treatment effects for remote CBT against usual care, but generally no retained pain advantage at three to twelve months (Rosser et al., 2023). Most interventions were internet programmes; the evidence is not specifically about modern AI or every mobile app. Adverse-event information was insufficient and inconsistent. Neither a low-intensity label nor lack of reported events establishes safety. A digital study must also consider worsening function, delayed assessment and participants who disengage. An absence of follow-up benefit should remain visible beside a positive post-treatment estimate.
Sources: Rosser et al., 2023
Implications and unanswered questions
A proposed reflection tool might help someone describe pain interference, coping priorities and questions for their healthcare team. That is a possible support function, not established efficacy. Claims should focus on what was measured and avoid suggesting that a different mindset eliminates pain. Direct product research should evaluate activity and function, distress, sleep, appropriate use of care and deterioration, with follow-up after use ends. It should distinguish primary pain from specific secondary conditions and account for physical accessibility and concurrent care. These are proposed research priorities inferred from the evidence gaps. The cited studies do not establish clinical benefits for Umbrella Journal, Ella or Nuggets.
Sources: Williams et al., 2020; Rosser et al., 2023; NICE, 2021; Cherkin et al., 2016
References
Links open the original papers or official sources. Access labels describe the material assessed for this review.
National Institute for Health and Care Excellence (2021). Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain. NICE guideline NG193.
Access assessed: Official indexed recommendations. Full evidence review not assessed.
Williams, A. C. de C., Fisher, E., Hearn, L., & Eccleston, C. (2020). Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database of Systematic Reviews, 2020(8), CD007407. 10.1002/14651858.CD007407.pub4
Access assessed: Full PMC text.
Cherkin, D. C., Sherman, K. J., Balderson, B. H., Cook, A. J., Anderson, M. L., Hawkes, R. J., Hansen, K. E., & Turner, J. A. (2016). Effect of Mindfulness-Based Stress Reduction vs Cognitive Behavioral Therapy or Usual Care on Back Pain and Functional Limitations in Adults With Chronic Low Back Pain: A Randomized Clinical Trial. JAMA, 315(12), 1240–1249. 10.1001/jama.2016.2323
Access assessed: Full PMC text, including abstract, outcomes and funding sections.
Rosser, B. A., Fisher, E., Janjua, S., Eccleston, C., Keogh, E., & Duggan, G. (2023). Psychological therapies delivered remotely for the management of chronic pain (excluding headache) in adults. Cochrane Database of Systematic Reviews, 2023(8), CD013863. 10.1002/14651858.CD013863.pub2
Access assessed: Cochrane public summary and complete abstract.
This evidence review is educational. It does not provide an individual diagnosis or treatment plan. Read the review methods, access limits, and clinical-review status.